Together with heterodimeric partner S100a8, S100a9 is a major biomarker of inflammation both in released form in serum and through increased expression in epithelial tissue and many tumour models
| Inventor | Institute |
|---|---|
| Nancy Hogg | Cancer Research UK, London Research Institute: Lincoln's Inn Fields |
| Cat. #: | 153165 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Cell signaling and signal transduction;Immunology |
| Application: | FACS ; WB |
| Target: | S100a9 |
| Reactivity: | Mouse |
| Clone: | NH6 |
| Host: | Rabbit |
| Class: | Polyclonal |
| Alternate name: | mMRP-14, calgranulin B |
|---|---|
| Product description: | Together with heterodimeric partner S100a8, S100a9 is a major biomarker of inflammation both in released form in serum and through increased expression in epithelial tissue and many tumour models |
| Conjugation: | Unconjugated |
| Molecular weight: | 14 kDa |
| Immunogen: | Recombinant mouse S100-a9 (mMRP-14) |
| Target background: | Together with heterodimeric partner S100a8, S100a9 is a major biomarker of inflammation both in released form in serum and through increased expression in epithelial tissue and many tumour models |
|---|
| Format: | Liquid |
|---|---|
| Storage buffer: | Whole serum |
| Storage conditions: | -80° C |
| Shipping conditions: | Dry ice |
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151016 | Anti-CyclinA [E72.1] |
Key Info
Anti-CyclinA [E72.1]
|
View Tool | |||||||||||||||||||
| 151022 | Anti-IL12 [1-1A4] |
Key Info
Anti-IL12 [1-1A4]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.